- BRCA proteins impact cells’ ability to repair DNA damage. The BRCA genes (BRCA1 and BRCA2) are tumor suppressor genes, which means that they prevent healthy cells from becoming cancerous. Their normal function is to repair damage to DNA, but when BRCA1 or BRCA2 is mutated and doesn’t work correctly, the accumulation of unrepaired DNA damage can ultimately lead to unregulated cell growth, or cancer.
- BRCA mutations increase a person’s risk of several cancer types, including pancreatic. All genes exist in the body in pairs – meaning that you inherit one copy (or version) from each parent. People can be born with one healthy and one mutated version of BRCA, leading to an increased (but not inevitable) lifetime cancer risk. Cancer could develop only if the second, healthy copy of the BRCA1 or BRCA2 gene gets mutated or altered, which could happen due to an environmental exposure (like smoking) or a mistake in the cellular genetic machinery.
- Ashkenazi Jews have a higher rate of BRCA mutations than the general American population. It is thought that around one in 40 individuals of Ashkenazi Jewish descent carry a BRCA1 or BRCA2 mutation. By contrast, studies have suggested that BRCA mutations occur in the range of one in 400 to one in 800 within the general non-Ashkenazi Jewish population.
- Genetic counselors and screening programs can help determine and monitor risk. If you have two or more first-degree relatives who have had pancreatic cancer, a first-degree relative who developed pancreatic cancer before the age of 50, or an inherited genetic syndrome associated with pancreatic cancer (such as a known BRCA mutation), you may have an increased risk of developing pancreatic cancer. The Pancreatic Cancer Action Network strongly recommends consulting with a genetic counselor to determine your risk and eligibility for a screening program.
- For those with cancer, mutations to BRCA can inform and improve treatment Preliminary evidence suggests that cancer cells with BRCA mutations may respond particularly well to a certain type of chemotherapy as well as a targeted therapy called PARP inhibition.
Every pancreatic tumor is different, and the Pancreatic Cancer Action Network strongly recommends molecular profiling of your tumor to help determine the best treatment options.
“Knowledge of a germline (inherited) BRCA1 or BRCA2 mutation can affect an entire family, not just an individual,” said Alison Klein, MHS, PhD, professor of oncology, pathology and epidemiology at Johns Hopkins University, and member of PanCAN’s Scientific and Medical Advisory Board. “It’s important to consult with a genetic counselor to determine who should be tested and to understand how to interpret results.”
Klein continued: “The more we learn about the genetics of pancreatic cancer, the more complexity we uncover. It’s important for people to know their family history so they can understand their risk of developing pancreatic and other cancer types, and to know the genetic features of their tumor, so that they can be aware of treatment options that might be best for them.”
Our Patient Central Associates can provide more information about topics related to pancreatic cancer, including risk factors, genetic counseling, treatment options and molecular profiling. Contact an Associate today.